Skip to main content
. 2019 Mar 18;39:10. doi: 10.1186/s40880-019-0349-9
ECOG score Grade I recommendations Grade II recommendations Grade III recommendations
0–1 Apatinib (Evidence 1A) Mono-chemotherapy (Evidence 3) PD-1 monoclonal antibody (Evidence 1A)
Encourage participation in clinical trials
2 Encourage participation in clinical trials Best supportive care Mono-chemotherapy (Evidence 3)